MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.drup.2025.101330

Медицинская библиотека · Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2025

Lars2-signaling mediates platinum resistance by accumulating cancer stem cell population and suppressing anti-tumor immunity.

Wang Yuqing, Deng Min, Lei Haipeng, Miao Kai, Shu Xiaodong, Li Jianjie, Tang Dongyang, Feng Yangyang, Su Sek Man, Li Ling, Wang Yanjie, Sun Heng, Shao Fangyuan, An Tingting, Li Xiaoling, Zhou Fanlin, Xiang Tingxiu, Xu Xiaoling, Deng Chuxia

СтатьяПеревод пока не подготовлен

Аннотация

Platinum-based chemotherapy remains a cornerstone of cancer treatment; however, its clinical efficacy is frequently compromised by acquired drug resistance. Our study elucidated a novel resistance mechanism mediated by LARS2 signaling in mammary tumors. Through comprehensive multi-omics analyses of cancer patients, mouse models, and functional validation, we demonstrated that platinum treatment upregulates LARS2 via a danger-triggered host response during resistant tumor progression, concomitant with increased chromatin accessibility. This signaling drives drug resistance through two key mechanisms: enrichment of cancer stem cells and promotion of TGF-β-mediated immunosuppression, as evidenced by M2 macrophage polarization and CD8+ T cell exhaustion. Importantly, we developed an effective therapeutic strategy combining carboplatin with LARS2 signaling pathway inhibition, which successfully reversed platinum resistance and restored PD-1 checkpoint blockade sensitivity in preclinical models. These findings not only advance our understanding of chemotherapy resistance, but also provide a translatable therapeutic framework for breast cancer and other platinum-treated malignancies.

Для цитирования: Wang Yuqing, Deng Min, Lei Haipeng, Miao Kai, Shu Xiaodong, Li Jianjie, Tang Dongyang, Feng Yangyang, Su Sek Man, Li Ling, Wang Yanjie, Sun Heng, Shao Fangyuan, An Tingting, Li Xiaoling, Zhou Fanlin, Xiang Tingxiu, Xu Xiaoling, Deng Chuxia. Lars2-signaling mediates platinum resistance by accumulating cancer stem cell population and suppressing anti-tumor immunity.. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy. 2025. DOI: 10.1016/j.drup.2025.101330.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.